Loading stock data…
Revelation Biosciences, Inc. (REVB)
$1.04+0.06 (+6.12%)
After Hours$1.03-0.01 (-0.96%)· Last close Jun 29
Revelation Biosciences, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Revelation Biosciences, Inc. in the Healthcare sector is trading at $1.04 with a market capitalization of $4M. Wall Street consensus targets $19.25 (2 analysts), implying a +1751.0% move over the next 12 months. The stock is currently near its 52-week low of $0.88, remaining 62.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +1751.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$3.09M↓ | -$2.57M↓ | -$1.94M↑ | -$2.46M↓ | -$2.09M |
| Net Income | -$3.01M↓ | -$2.51M↓ | -$1.91M↑ | -$2.44M↓ | -$2.05M |
Peer Comparison
JNJUNHPFE
Fundamentals
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.06M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-76.00%
Volume
Today's trading volume
38,301
Recent News
BC-Most Active Stocks
Blue Gold Ltd. 23,969,833 5.8694
The early winner in the 'Dexit' war for corporate relocations: Nevada
Companies from Andreessen Horowitz to Pershing Square are choosing Nevada as they follow Elon Musk's exit from Delaware.